Pomalidomide
Pomalidomide is the generic name for the trade name chemotherapy drug Pomalyst®. In some cases, health care professionals may use the trade name Pomalyst® when referring to the generic drug pomalidomide.
Drug type: Pomalidomide is classified as an “immunomodulatory agent with antineoplastic activity,” and an “anti-angiogenic agent.” (For more detail, see “How this drug works” section below).
What Pomalidomide Is Used For:
- For treatment of multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of the last therapy.
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.